Apogem Capital’s Blue Bird Corp BLBD Stock Holding History

Apogem Capital’s Portfolio BLBD Stock Details BLBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,000	Closed	-$200K	–	192
2021 Q1	$200K	Buy	+8,000	New	+$183K	0.14%	157

Other funds holding BLBD

American Securities New York $3.93B AUM 52.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

Apogem Capital's BLBD Position: Q2 2021 in Review

Apogem Capital sold out of Blue Bird Corp (BLBD) in Q2 2021, closing a stake of 8,000 shares — an estimated $200K sold.

Apogem Capital first reported a position in BLBD in Q1 2021 and held it in 1 quarter. The position peaked at $200K in Q1 2021. 90 funds tracked by Wall St. Rank hold BLBD as of Q2 2021.

Apogem Capital reported no remaining Blue Bird Corp position as of Q2 2021 after selling out during the quarter.
Apogem Capital sold 8,000 Blue Bird Corp shares in Q2 2021, an estimated $200K.
Apogem Capital first reported a position in Blue Bird Corp in Q1 2021 and held it in 1 quarter.
Apogem Capital's Blue Bird Corp position peaked at $200K in Q1 2021.
90 funds tracked by Wall St. Rank held Blue Bird Corp as of Q2 2021.

Based on Apogem Capital's 13F filing for Q2 2021, filed 16 Aug 2021.